HMD 0.00% 2.2¢ heramed limited

Ann: HeraBEAT Plus Clinical Trial Study Details, page-38

  1. 1,071 Posts.
    lightbulb Created with Sketch. 179
    100% agree, its great to have you or board. You always bring great content.
    This tech aims to provide the reassurance and peace of mind of a medical-grade fetal wellness test without the cost or discomfort associated with repeated visits to the OB/GYN or hospital.
    According to the company, about 50% of expecting mothers in the United States don't have access to an obstetrician, where the cost of pregnancy and newborn care is estimated at about US$30,000.

    HeraMED has a distribution agreement with Teva Pharmaceutical Industries (NYSE:TEVA | TASE:TEVA) whose subsidiary Abic is the exclusive distributor of the product in Israel. HeraMED’s partnership with TEVA allows the company to earn US$2+ million over the first three years, delivering product validation, market scope and significant early revenue generation.
    Last edited by Alby118: 23/02/20
 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.000(0.00%)
Mkt cap ! $13.93M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $42 1.888K

Buyers (Bids)

No. Vol. Price($)
2 70618 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 146859 1
View Market Depth
Last trade - 10.04am 06/09/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.